Managing postoperative biochemical relapse in prostate cancer, from the perspective of the Francophone group of Urological radiotherapy (GFRU)
Authors:
- 16 September 2023
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 120, 102626
Abstract
No abstract availableKeywords
This publication has 123 references indexed in Scilit:
- Optimal Definition of Biochemical Recurrence After Radical Prostatectomy Depends on Pathologic Risk Factors: Identifying Candidates for Early Salvage TherapyEuropean Urology, 2014
- Treatment of Prostate Cancer With Intermittent Versus Continuous Androgen Deprivation: A Systematic Review of Randomized TrialsJournal of Clinical Oncology, 2013
- Meta-analysis of the Alpha/Beta Ratio for Prostate Cancer in the Presence of an Overall Time Factor: Bad News, Good News, or No News?International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2013
- Long-Term Risk of Clinical Progression After Biochemical Recurrence Following Radical Prostatectomy: The Impact of Time from Surgery to RecurrenceEuropean Urology, 2011
- Abiraterone and Increased Survival in Metastatic Prostate CancerNew England Journal of Medicine, 2011
- Salvage radiation in men after prostate‐specific antigen failure and the risk of deathCancer, 2011
- Development of RTOG Consensus Guidelines for the Definition of the Clinical Target Volume for Postoperative Conformal Radiation Therapy for Prostate CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Potential Surrogate Endpoints for Prostate Cancer Survival: Analysis of a Phase III Randomized TrialJNCI: Journal of the National Cancer Institute, 2009
- Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate CancerClinical Cancer Research, 2008
- Prostate Cancer–Specific Survival Following Salvage Radiotherapy vs Observation in Men With Biochemical Recurrence After Radical ProstatectomyJAMA, 2008